ChartRow logo
JAZZ
Jazz Pharmaceuticals plc Common Stock (Ireland)Stock · Health Care
$245.84−$3.11 (-1.25%)as of market close, Aug 13, 2026
☾ After hours:$245.85+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

JAZZ financial statements

The full income statement, balance sheet, and cash-flow statement for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 61.8M2024-09 60.5M2024-12 60.7M2025-03 61.6M2025-06 60.7M2025-09 60.8M2025-12 61.6M2026-03 62.7M2026-06 64.9M+5.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
4.27B
YoY+4.9%
4.07B
YoY+6.1%
3.83B
YoY+4.8%
3.66B
YoY+18.3%
3.09B
YoY+30.9%
Research & development
783M
YoY-11.5%
884M
YoY+4.0%
850M
YoY+43.9%
590M
YoY+16.7%
506M
YoY+50.8%
Selling, general & administrative
1.81B
YoY+30.6%
1.39B
YoY+3.1%
1.34B
YoY-5.2%
1.42B
YoY-2.4%
1.45B
YoY+69.9%
Amortization of intangibles
655M
YoY+4.4%
627M
YoY+3.1%
608M
YoY+1.5%
599M
YoY+14.0%
526M
YoY+102.5%
Operating income
-430M
YoY-160.0%
717M
YoY+23.9%
579M
YoY+983.0%
-65.5M
YoY-138.5%
170M
YoY-55.0%
Interest expense
32.8M
YoY+0.0%
32.8M
YoY-63.5%
89.9M
YoY+2.6%
Interest & investment income
85.8M
YoY-19.3%
106M
YoY+63.3%
65.1M
YoY+466.1%
11.5M
YoY+538.9%
1.80M
YoY-83.8%
Equity-method income
-732K
YoY+55.9%
-1.66M
YoY+44.8%
-3.01M
YoY+69.7%
-9.92M
YoY-1289.5%
-714K
YoY+75.9%
Pre-tax income
-628M
YoY-233.5%
470M
YoY+57.9%
298M
YoY+179.9%
-373M
YoY-230.4%
-113M
YoY-141.0%
Income tax
-272M
YoY-198.0%
-91.4M
YoY+23.8%
-120M
YoY+24.4%
-159M
YoY-173.4%
216M
YoY+544.8%
Net income
-356M
YoY-163.6%
560M
YoY+35.0%
415M
YoY+285.1%
-224M
YoY+32.0%
-330M
YoY-238.2%
-$5.84
YoY-167.5%
$8.65
YoY+41.8%
$6.10
YoY+270.4%
-$3.58
YoY+35.1%
-$5.52
YoY-230.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
4.17B
YoY-10.0%
4.63B
YoY+34.7%
3.44B
YoY+31.8%
2.61B
YoY-0.2%
2.61B
YoY-8.0%
11.7B
YoY-2.9%
12.0B
YoY+5.4%
11.4B
YoY+5.2%
10.8B
YoY-11.9%
12.3B
YoY+88.2%
2.24B
YoY+115.9%
1.04B
YoY-32.4%
1.54B
YoY+64.7%
933M
YoY+15.3%
809M
YoY+23.8%
Long-term debt
4.33B
YoY-28.8%
6.08B
YoY+19.0%
5.11B
YoY-10.3%
5.69B
YoY-5.4%
6.02B
YoY+225.6%
Deferred revenue (non-current)
0.00
YoY-100.0%
463K
YoY-80.0%
Non-current lease liability
50.9M
YoY+30.7%
38.9M
YoY-34.3%
59.2M
YoY-17.6%
71.8M
YoY-17.6%
87.2M
YoY-37.7%
Operating lease liability (total)
65.2M
YoY+22.3%
53.3M
YoY-31.9%
78.2M
YoY-10.5%
87.4M
YoY-14.8%
103M
YoY-33.6%
Finance lease liability (total)
3.88M
YoY-22.6%
5.01M
YoY-8.4%
5.47M
YoY-2.2%
5.59M
YoY-16.2%
6.67M
Finance lease liability
3.44M
YoY-24.6%
4.56M
YoY-9.5%
5.04M
YoY-3.3%
5.21M
YoY-16.9%
6.27M
Deferred tax liabilities
595M
YoY-12.2%
677M
YoY-20.2%
848M
YoY-10.2%
944M
YoY-27.4%
1.30B
YoY+897.4%
Other non-current liabilities
124M
YoY+43.6%
86.6M
YoY-17.3%
105M
YoY-1.9%
107M
YoY-8.7%
117M
YoY+15.7%
4.32B
YoY+5.5%
4.09B
YoY+9.5%
3.74B
YoY+21.1%
3.09B
YoY-22.2%
3.97B
YoY+8.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.36B
YoY-2.9%
1.40B
YoY+27.8%
1.09B
YoY-14.1%
1.27B
YoY+63.4%
779M
YoY-13.5%
-1.51B
YoY-197.1%
-508M
YoY-211.7%
-163M
YoY+63.5%
-446M
YoY+91.4%
-5.21B
YoY-417.2%
-873M
YoY-4357.1%
20.5M
YoY+106.7%
-305M
YoY+42.3%
-529M
YoY-113.3%
3.97B
YoY+651.9%
FX effect on cash
6.55M
YoY+491.3%
-1.68M
YoY-247.3%
1.14M
YoY+118.3%
-6.22M
YoY-94.0%
-3.21M
YoY-957.5%
Net change in cash
-1.02B
YoY-212.6%
907M
YoY+45.1%
625M
YoY+115.4%
290M
YoY+162.2%
-466M
YoY-210.9%
Interest paid
249M
YoY-21.0%
315M
YoY-5.5%
333M
YoY+23.1%
271M
YoY+95.8%
138M
YoY+225.6%
Income taxes paid
122M
YoY+6.0%
115M
YoY-35.4%
178M
YoY+87.9%
94.7M
YoY-65.1%
271M
YoY+19.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
10.5B
YoY+39.9%
7.48B
YoY-3.4%
7.74B
YoY-22.8%
10.0B
YoY+27.5%
7.87B
YoY-15.4%
P/E
13.4×
YoY-86.2%
96.9×
P/S
2.5×
YoY+33.4%
1.8×
YoY-9.9%
2.0×
YoY-27.1%
2.8×
YoY+10.1%
2.5×
YoY-35.4%
P/B
2.4×
YoY+32.6%
1.8×
YoY-17.7%
2.2×
YoY-39.3%
3.7×
YoY+84.2%
2.0×
YoY-21.9%
P/FCF
8.1×
YoY+46.5%
5.5×
YoY-11.6%
6.2×
YoY-33.1%
9.3×
YoY-11.2%
10.5×
YoY-0.3%
7.5%
YoY+625.3%
1.0%
12.4%
YoY-31.7%
18.2%
YoY+13.1%
16.1%
YoY+49.4%
10.7%
YoY+12.6%
9.5%
YoY+0.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: JAZZ's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all JAZZ filings on SEC EDGAR → Not investment advice.